Semaglutide delays gastric emptying and commonly causes gastrointestinal effects
The study aimed to evaluate whether semaglutide and tirzepatide were linked to reduced rates of neurodegenerative and cerebrovascular conditions compared to other antidiabetic therapies
The retrospective study evaluated nearly 1,000 patients with Type 2 diabetes who were treated at the Cole Eye Institute between 2012 and 2023
In recent years, Semaglutide has also gained FDA approval for weight loss under the name Wegovy
(Source: Stanford Medicine, 2026) Some Sellers Lacked Proper Licensing The same study noted that some compounding facilities lacked licenses to perform sterile compounding or had recently faced disciplinary actions from state pharmacy boards meaning the risk wasnt limited to the drug formulation itself, but extended to the basic manufacturing conditions
It should be prescribed by a licensed physician based on: Individual glycemic control requirements Weight-related health concerns Tolerance to medication Presence of co-existing conditions (e.g., heart disease) Never self-medicate or adjust the dose without professional advice